| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2015 | MTD Mettler Toledo International Inc/ | Donnelly William P | Executive Vice President | Sell | 15,250 | $327.52 | $4,994,685.00 | -68.5% | |
| Nov 6, 2015 | WST West Pharmaceutical Services Inc | Anderson Michael A | Vice President &Treasurer | Sell | 3,000 | $62.18 | $186,540.00 | -4.7% | |
| Nov 5, 2015 | WST West Pharmaceutical Services Inc | Anderson Michael A | Vice President &Treasurer | Sell | 10,000 | $61.98 | $619,817.00 | -13.4% | |
| Nov 5, 2015 | MYGN Myriad Genetics Inc | Dreismann Heinrich | Director | Sell | 60,000 | $44.44 | $2,666,118.00 | -75.0% | |
| Nov 4, 2015 | MYGN Myriad Genetics Inc | Marsh Richard M | E.v.p., General Counsel | Sell | 35,000 | $44.50 | $1,557,500.00 | -33.9% | |
| Nov 4, 2015 | TMO Thermo Fisher Scientific Inc. | Hoogasian Seth H | Sr. VP, Gen. Counsel &Sec. | Sell | 1,692 | $135.00 | $228,420.00 | -4.8% | |
| Nov 4, 2015 | WST West Pharmaceutical Services Inc | Malone Daniel | Vice President &Controller | Sell | 4,456 | $61.65 | $274,712.40 | -16.5% | |
| Nov 4, 2015 | CRL Charles River Laboratories International, Inc. | Ackerman Thomas F | Senior Financial Advisor | Sell | 21,612 | $70.01 | $1,512,971.00 | -6.7% | |
| Nov 3, 2015 | TMO Thermo Fisher Scientific Inc. | Harris C Martin | Director | Sell | 531 | $134.35 | $71,339.85 | -11.6% | |
| Nov 3, 2015 | RVTY Revvity, Inc. | Wilson Frank Anders | Please See Remarks | Sell | 16,380 | $52.69 | $863,013.06 | -22.7% | |
| Nov 2, 2015 | NEO Neogenomics Inc | Crowther Bruce K | Director | Buy | 6,400 | $7.81 | $49,977.60 | +178.8% | |
| Nov 2, 2015 | CRL Charles River Laboratories International, Inc. | Chubb Stephen D | Director | Sell | 2,000 | $66.57 | $133,145.40 | -12.9% | |
| Nov 2, 2015 | TMO Thermo Fisher Scientific Inc. | Manzi Jim P52 | Director | Sell | 3,050 | $133.49 | $407,145.14 | -1.8% | |
| Oct 30, 2015 | DHR Danaher Corp /de/ | Daniel William K | EVP | Sell | 39,740 | $93.04 | $3,697,508.52 | -16.6% | |
| Oct 28, 2015 | MYGN Myriad Genetics Inc | King Gary A. | Exec. VP International Ops | Sell | 10,000 | $42.82 | $428,200.00 | -11.0% | |
| Oct 28, 2015 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 50,962 | $41.86 | $2,133,269.32 | -41.9% | |
| Oct 27, 2015 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 24,767 | $41.80 | $1,035,260.60 | -8.0% | |
| Oct 23, 2015 | DHR Danaher Corp /de/ | Joyce Thomas Patrick Jr | President And CEO | Sell | 25,300 | $93.47 | $2,364,892.20 | -17.9% | |
| Oct 23, 2015 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 2,000 | $50.00 | $100,000.00 | -15.1% | |
| Oct 23, 2015 | DHR Danaher Corp /de/ | Lutz Robert S | Svp-chief Accounting Officer | Sell | 26,400 | $93.45 | $2,467,027.20 | -62.1% | |
| Oct 23, 2015 | DHR Danaher Corp /de/ | Comas Daniel L | EVP &CFO | Sell | 36,200 | $92.71 | $3,356,102.00 | -26.6% | |
| Sep 17, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 75,000 | $6.18 | $463,200.00 | -2.5% | |
| Sep 17, 2015 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 25,000 | $130.00 | $3,250,000.00 | -6.5% | |
| Sep 17, 2015 | MYGN Myriad Genetics Inc | Lanchbury Jerry S81 | Chief Scientific Officer | Sell | 60,270 | $39.89 | $2,403,921.30 | -21.1% | |
| Sep 16, 2015 | RDNT Radnet, Inc. | Hames Norman R56 | Executive Vice President | Sell | 40,000 | $6.04 | $241,550.00 | -2.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.